![\"\"](\"https:\/\/demo101.websartech.com\/taal\/wp-content\/uploads\/2025\/05\/final-300x300.png\")
<\/p>\n<\/p>\n
Thanks to advances in treatment, many people living with HIV (PLHIV) have near-normal life expectancies. But as PLHIV age, non-AIDS comorbidities\u2014especially cardiovascular disease (CVD)\u2014are becoming major concerns. Recent studies show that PLHIV<\/a> have significantly higher risk of heart disease, stroke, and metabolic complications. In this post, we dig into what the data says, why cardiovascular health is so important, and what can be done to protect the heart.<\/p>\n These findings suggest that cardiovascular health is no longer an afterthought\u2014it\u2019s central to long-term health for PLHIV.<\/p>\n Cardiovascular disease is one of the leading causes of morbidity and mortality in PLHIV today. With risks that are over twice<\/strong> that of HIV-negative populations, and significant metabolic complications even in young people, we can no longer treat heart health as peripheral. Prevention, early detection, healthy lifestyle, good treatment, and integrated care are paths forward. PLHIV deserve health that includes strong hearts, not just strong viral suppression.<\/p>\n <\/p>\n Frequently Asked Questions (FAQ)<\/strong><\/p>\n <\/p>\n Q1: At what age should PLHIV start cardiovascular screening?<\/strong> <\/p>\n Q2: Can changing ART reduce heart disease risk?<\/strong> <\/p>\n Q3: Are there lifestyle changes that make a big difference?<\/strong> <\/p>\n Q4: How does viral suppression affect heart health?<\/strong> <\/p>\n Q5: Are young people with HIV also at risk of heart disease?<\/strong> Q6: What type of doctor should PLHIV see for heart concerns?<\/strong> <\/p>\n <\/p>\nWhat Recent Research Reveals<\/strong><\/h3>\n
\n
Why PLHIV Are at Higher Cardiovascular Risk<\/strong><\/h3>\n
\n
\nEven with ART, HIV causes a state of low-grade chronic inflammation, which damages blood vessels and promotes atherosclerosis.<\/li>\n
\nSome antiretroviral therapies<\/a> (especially older regimens) are associated with lipid changes, fat redistribution, insulin resistance. Raised cholesterol and triglycerides are more common among PLHIV.<\/li>\n
\nPLHIV may also have higher rates of smoking, poor diet, physical inactivity, other infections\u2014all adding to cardiovascular risk.<\/li>\n
\nAs seen in the adolescent study, detectable viral load (VL) and low CD4 counts correlate with higher CVD risk. Maintaining viral suppression is protective.<\/li>\n<\/ol>\nThe Real Life Impact<\/h3>\n
\n
What Can Be Done: Prevention and Control<\/strong><\/h3>\n
\n
\nPLHIV should get regular checks for cholesterol, blood pressure, blood sugar. Viral load monitoring and CD4 counts matter not just for HIV, but for assessing cardiovascular risk.<\/li>\n
\nExercise, healthy diet, quitting smoking, managing weight are foundational. Even moderate improvements in diet or activity can reduce risk substantially.<\/li>\n
\nWhen possible, selecting ART with lower risk of metabolic side effects helps. Close medical supervision allows switching if side effects like hyperlipidemia emerge.<\/li>\n
\nSuppressing viral load reduces immune activation and inflammation. Thus early diagnosis, adherence to treatment, and access to quality HIV aids treatment and services<\/a><\/strong> are critical.<\/li>\n
\nClinics offering combined HIV care plus cardiovascular risk management (lipid clinics, cardiology referrals) are more effective than siloed care.<\/li>\n<\/ol>\nConclusion<\/strong><\/h3>\n
\nMany guidelines recommend starting in early adulthood, but especially once on ART for several years, or if risk factors (smoking, high lipid levels, family history) are present.<\/p>\n
\nYes\u2014some ART medications are more likely to cause metabolic side effects. Discuss with your HIV specialist doctor<\/strong> about safer options and monitoring.<\/p>\n
\nAbsolutely. Regular physical activity, healthy diet (low saturated fats, good fiber), quitting smoking, limiting alcohol, and managing body weight have strong evidence for reducing cardiovascular risk.<\/p>\n
Maintaining an undetectable viral load lowers chronic inflammation and immune activation, which are major drivers of cardiovascular disease in PLHIV. Staying adherent to ART is protective for the heart.<\/p>\n
Yes. Research shows that even adolescents and young adults with HIV can have metabolic issues (raised cholesterol, triglycerides) and higher cardiovascular risk, especially with unsuppressed HIV.<\/p>\n
An HIV specialist should remain your primary provider, but referrals to cardiologists or lipid clinics are recommended for those with persistent risk factors, abnormal labs, or existing cardiovascular disease.<\/p>\n